|
Giorgio Carta, University of Virginia
Olivier Dapremont, Ampac Fine Chemicals
Georges Guiochon, University of Tennessee and ORNL
Lois Ann Beaver, LAB Enterprises
Giorgio Carta, University of Virginia
Olivier Dapremont, Ampac Fine Chemicals
Georges Guiochon, University of Tennessee and ORNL
Christopher Welch, Merck & Co., Inc.
Igor Quinones-Garcia, Schering-Plough Corporation
Scientific Advisory Committee
Steven M. Cramer, Rensselaer Polytechnic Institute
Attila Felinger, University of Pecs, Hungary
Alan K. Hunter, Pfizer, Inc.
Alois Jungbauer, BOKU, Vienna
Abraham M. Lenhoff, University of Delaware
Marco Mazzotti, ETH Zurich
Kathleen Mihlbachler, Bristol-Myers Squibb, Co.
Larry Miller, Amgen, Inc.
Massimo Morbidelli, ETH Zurich
Joan Newburger, Johnson & Johnson Consumer Products Worldwide
Neville G. Pinto, University of Cincinnati
David Robbins, MedImmune, Inc.
Andreas Seidel-Morgenstern, Max-Planck Institute, Magdeburg
Industrial Advisory Committee
Lou Bellafiore, Asahi Kasei Technikrom, Inc.
Geoffrey B. Cox, Chiral Technologies, Inc.
Russell Frost, Bio-Rad Laboratories, Inc.
T. Nicholas Mitchell, Sohve Corporation
Ian Sellick, Pall Life Sciences, Inc.
Franco Spoldi, Perkin Elmer LAS, Inc.
Eric Valery, Novasep SAS
Gary W. Yanik, PDR-Chiral, Inc.
|
